Literature DB >> 22018127

Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Patricia L Bright1, Abigail Norris Turner, Charles S Morrison, Emelita L Wong, Cynthia Kwok, Irina Yacobson, Rachel A Royce, Heidi O Tucker, Paul D Blumenthal.   

Abstract

BACKGROUND: The effect of combined oral contraceptives (COCs) and depot-medroxyprogesterone acetate (DMPA) on the area of cervical ectopy is not well understood. STUDY
DESIGN: From 1996 to 1999, we recruited women not using hormonal contraception from two family planning centers in Baltimore, MD. Upon study entry and 3, 6 and 12 months after the initial visit, participants were interviewed and received visual cervical examinations with photography. Ectopy was measured from digitized photographs and was analyzed both continuously and categorically (small [≤0.48 cm(2)] vs. large [>0.48 cm(2)]).
RESULTS: Of 1003 enrolled women, 802 returned for at least one follow-up visit. At 12 months, the numbers of women using COCs, DMPA or no hormonal method at least 50% of the time since the prior visit were 230, 76 and 229, respectively. After multivariable adjustment, COC use (vs. no hormonal use) was associated with large area of ectopy (odds ratio [OR]: 1.8, 95% confidence interval [CI]: 1.0-3.3). No significant relationship was observed between DMPA and large area of ectopy (OR: 0.5, 95% CI: 0.2-1.3). The incidence of large area of ectopy by contraceptive exposure (COC, DMPA or no hormonal method) was 17.4 (CI: 11.8-24.6), 10.9 (CI: 4.4-22.4) and 4.6 (CI: 2.2-8.4) per 100 woman-years, respectively.
CONCLUSIONS: Use of COCs, but not DMPA, was associated with large area of cervical ectopy. Area of ectopy at baseline was the strongest predictor of area of ectopy at follow-up.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018127      PMCID: PMC4262923          DOI: 10.1016/j.contraception.2011.02.002

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  35 in total

Review 1.  Histologic development of cervical ectopy: relationship to reproductive hormones.

Authors:  D L Jacobson; L Peralta; N M Graham; J Zenilman
Journal:  Sex Transm Dis       Date:  2000-05       Impact factor: 2.830

2.  Computerized planimetry versus clinical assessment for the measurement of cervical ectopia.

Authors:  C S Morrison; P Bright; P D Blumenthal; I Yacobson; C Kwok; S Zdenek; Z Pan
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

3.  Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study.

Authors:  Ludo Lavreys; Jared M Baeten; Harold L Martin; Julie Overbaugh; Kishorchandra Mandaliya; Jeckoniah Ndinya-Achola; Joan K Kreiss
Journal:  AIDS       Date:  2004-03-05       Impact factor: 4.177

4.  Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection.

Authors:  A B Moscicki; Y Ma; C Holland; S H Vermund
Journal:  J Infect Dis       Date:  2001-02-21       Impact factor: 5.226

5.  The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.

Authors:  C K Mauck; M M Callahan; J Baker; K Arbogast; R Veazey; R Stock; Z Pan; C S Morrison; M Chen-Mok; D F Archer; H L Gabelnick
Journal:  Contraception       Date:  1999-07       Impact factor: 3.375

6.  Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents.

Authors:  D L Jacobson; L Peralta; M Farmer; N M Graham; C Gaydos; J Zenilman
Journal:  Sex Transm Dis       Date:  2000-07       Impact factor: 2.830

7.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

Authors:  J M Baeten; P M Nyange; B A Richardson; L Lavreys; B Chohan; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

8.  High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies.

Authors:  G Dowe; M Smikle; S D King; H Wynter; J Frederick; T Hylton-Kong
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

9.  Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections.

Authors:  Charles S Morrison; Patricia Bright; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Charlotte A Gaydos; Heidi T Tucker; Paul D Blumenthal
Journal:  Sex Transm Dis       Date:  2004-09       Impact factor: 2.830

10.  Human papillomavirus infection and cervical ectopy.

Authors:  L Rocha-Zavaleta; G Yescas; R M Cruz; F Cruz-Talonia
Journal:  Int J Gynaecol Obstet       Date:  2004-06       Impact factor: 3.561

View more
  10 in total

1.  Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls.

Authors:  Mimi Ghosh; Mariel Jais; Roshni Biswas; Jason Jarin; Jason Daniels; Christopher Joy; Monika Juzumaite; Vanessa Emmanuel; Veronica Gomez-Lobo
Journal:  Am J Reprod Immunol       Date:  2018-03-13       Impact factor: 3.886

2.  Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020.

Authors:  Mamaru Getinet; Molla Taye; Abebe Ayinalem; Menberesibhat Gitie
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

3.  Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model.

Authors:  Jiafen Hu; Sarah A Brendle; Jingwei J Li; Vonn Walter; Nancy M Cladel; Timothy Cooper; Debra A Shearer; Karla K Balogh; Neil D Christensen
Journal:  Viruses       Date:  2022-05-06       Impact factor: 5.818

4.  Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women.

Authors:  Amy Romer; Marcia L Shew; Susan Ofner; Melissa L Gilliam; Summer L Martins; J Dennis Fortenberry
Journal:  J Adolesc Health       Date:  2012-06-05       Impact factor: 5.012

5.  Cervical Ectropion and Intra-Uterine Contraceptive Device (IUCD): a five-year retrospective study of family planning clients of a tertiary health institution in Lagos Nigeria.

Authors:  Kikelomo Ololade Wright; Ahmadu Shehu Mohammed; Olajumoke Salisu-Olatunji; Yetunde Abiola Kuyinu
Journal:  BMC Res Notes       Date:  2014-12-23

6.  Living with uncertainty: acting in the best interests of women.

Authors:  Erica Gollub; Zena Stein
Journal:  AIDS Res Treat       Date:  2012-11-01

7.  Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa.

Authors:  Elisabeth Kleppa; Sigve D Holmen; Kristine Lillebø; Eyrun F Kjetland; Svein Gunnar Gundersen; Myra Taylor; Prashini Moodley; Mathias Onsrud
Journal:  Sex Transm Infect       Date:  2014-10-03       Impact factor: 3.519

Review 8.  Chlamydia prevalence in the general population: is there a sex difference? a systematic review.

Authors:  Patrick W Dielissen; Doreth A M Teunissen; Antoine L M Lagro-Janssen
Journal:  BMC Infect Dis       Date:  2013-11-11       Impact factor: 3.090

9.  Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.

Authors:  Suzanna C Francis; Yanwen Hou; Kathy Baisley; Janneke van de Wijgert; Deborah Watson-Jones; Trong T Ao; Carolina Herrera; Kaballa Maganja; Aura Andreasen; Saidi Kapiga; Gary R Coulton; Richard J Hayes; Robin J Shattock
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

10.  High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception.

Authors:  Deborah Bartz; Rie Maurer; Jessica Kremen; Jennifer M Fortin; Elizabeth Janiak; Alisa B Goldberg
Journal:  Contracept Reprod Med       Date:  2017-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.